A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD). (2023)

First Author: Dyson A

Attributed to: Homeostatic control of neuron excitability funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1523/eneuro.0461-22.2023

PubMed Identifier: 37185294

Publication URI: http://europepmc.org/abstract/MED/37185294

Type: Journal Article/Review

Volume: 10

Parent Publication: eNeuro

Issue: 5

ISSN: 2373-2822